Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older Muhammad A. Mujtaba; Ann Kathleen Gamilla-Crudo; Shehzad N. Merwat; Syed A. Hussain; Michael Kueht; Aftab Karim; Muhammad W. Khattak; Peggy J. Rooney; Khurram Jamil;

Position statement on the use of albumin in liver cirrhosis Graciela Castro-Narro; Carlos Moctezuma-Velázquez; Rene Male-Velázquez; Rafael Trejo-Estrada; Francisco Javier Bosques; Rosalba Moreno-Alcántar; Heriberto Rodríguez-Hernández; Aleida Bautista-Santos; Carlos Córtez-Hernández; Eira Cerda-Reyes; Juanita Pérez-Escobar; Juan Manuel Aldana-Ledesma; Jonathan Aguirre-Valadez; José Antonio Velarde Ruiz-Velasco; Raúl Contreras-Omaña; Godolfino Miranda-Zazueta; Monica del Rocío Reyes-Bastidas; Javier Manuel Meza-Cardona; Norberto Chávez-Tapia; Nicolas Joaquín Fernández-Pérez; Edgar Santino García-Jiménez; Aldo Torre;

Efficacy and safety of terlipressin and albumin vs. noradrenaline and albumin in adult patients with hepatorenal syndrome: A systematic review and meta-analysis Adnan Malik; Muhammad Imran Malik; Shahbaz Qureshi; Abdul Nadir;